FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893111821> ?p ?o ?g. }

• W2893111821 endingPage "e0006836" @default.
• W2893111821 startingPage "e0006836" @default.
• W2893111821 abstract "Chagas disease is a neglected tropical disease. About 6 to 8 million people are chronically infected and 10% to 15% develop irreversible gastrointestinal disorders, including megaesophagus. Treatment focuses on improving symptoms, and isosorbide and nifedipine may be used for this purpose.We conducted a systematic review to evaluate the effectiveness of pharmacological treatment for Chagas' megaesophagus. We searched MEDLINE, Embase and LILACS databases up to January 2018. We included both observational studies and RCTs evaluating the effects of isosorbide or nifedipine in adult patients with Chagas' megaesophagus. Two reviewers screened titles and abstracts, selected eligible studies and extracted data. We assessed the risk of bias using NIH 'Quality Assessment Tool for Before-After (Pre-Post) Studies with No Control Group' and RoB 2.0 tool. Overall quality of evidence was assessed using GRADE.We included eight studies (four crossover RCTs, four before-after studies). Three studies evaluated the effect of isosorbide on lower esophageal sphincter pressure (LESP), showing a significant reduction (mean difference -10.52mmHg, 95%CI -13.57 to-7.47, very low quality of evidence). Three studies reported the effect of isosorbide on esophageal emptying, showing a decrease in esophageal retention rates (mean difference -22.16%, 95%CI -29.94 to -14.38, low quality of evidence). In one study, patients on isosorbide reported improvement in the frequency and severity of dysphagia (moderate quality of evidence). Studies evaluating nifedipine observed a decrease in LESP but no effect on esophageal emptying (very low and low quality of evidence, respectively). Isosorbide had a higher incidence of headache as a side effect than nifedipine.Although limited, available evidence shows that both isosorbide and nifedipine are effective in reducing esophageal symptoms. Isosorbide appears to be more effective, and its use is supported by a larger number of studies; nifedipine, however, appears to have a better tolerability profile.PROSPERO CRD42017055143. ClinicalTrials.gov CRD42017055143." @default.
• W2893111821 created "2018-10-05" @default.
• W2893111821 creator A5000946479 @default.
• W2893111821 creator A5002861419 @default.
• W2893111821 creator A5035934697 @default.
• W2893111821 creator A5038528759 @default.
• W2893111821 creator A5064666151 @default.
• W2893111821 creator A5069024230 @default.
• W2893111821 creator A5074453447 @default.
• W2893111821 date "2018-09-28" @default.
• W2893111821 modified "2023-09-29" @default.
• W2893111821 title "Isosorbide and nifedipine for Chagas' megaesophagus: A systematic review and meta-analysis" @default.
• W2893111821 cites W132780432 @default.
• W2893111821 cites W1957652343 @default.
• W2893111821 cites W1970788359 @default.
• W2893111821 cites W1970803263 @default.
• W2893111821 cites W1984194904 @default.
• W2893111821 cites W1987123887 @default.
• W2893111821 cites W2020807326 @default.
• W2893111821 cites W2023838767 @default.
• W2893111821 cites W2031623447 @default.
• W2893111821 cites W2066103627 @default.
• W2893111821 cites W2075967653 @default.
• W2893111821 cites W2093675488 @default.
• W2893111821 cites W2135400982 @default.
• W2893111821 cites W2144967104 @default.
• W2893111821 cites W2156098321 @default.
• W2893111821 cites W2163119513 @default.
• W2893111821 cites W2168263934 @default.
• W2893111821 cites W2249791536 @default.
• W2893111821 cites W2297957446 @default.
• W2893111821 cites W2308339587 @default.
• W2893111821 cites W2417904482 @default.
• W2893111821 cites W2421267126 @default.
• W2893111821 cites W2460185918 @default.
• W2893111821 cites W246286872 @default.
• W2893111821 cites W2512512155 @default.
• W2893111821 cites W2605815369 @default.
• W2893111821 cites W2914655374 @default.
• W2893111821 cites W3152976895 @default.
• W2893111821 cites W4210980497 @default.
• W2893111821 cites W4210992500 @default.
• W2893111821 cites W4235938477 @default.
• W2893111821 cites W4250735135 @default.
• W2893111821 cites W4294215472 @default.
• W2893111821 doi "https://doi.org/10.1371/journal.pntd.0006836" @default.
• W2893111821 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6179300" @default.
• W2893111821 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30265663" @default.
• W2893111821 hasPublicationYear "2018" @default.
• W2893111821 type Work @default.
• W2893111821 sameAs 2893111821 @default.
• W2893111821 citedByCount "8" @default.
• W2893111821 countsByYear W28931118212020 @default.
• W2893111821 countsByYear W28931118212021 @default.
• W2893111821 countsByYear W28931118212022 @default.
• W2893111821 crossrefType "journal-article" @default.
• W2893111821 hasAuthorship W2893111821A5000946479 @default.
• W2893111821 hasAuthorship W2893111821A5002861419 @default.
• W2893111821 hasAuthorship W2893111821A5035934697 @default.
• W2893111821 hasAuthorship W2893111821A5038528759 @default.
• W2893111821 hasAuthorship W2893111821A5064666151 @default.
• W2893111821 hasAuthorship W2893111821A5069024230 @default.
• W2893111821 hasAuthorship W2893111821A5074453447 @default.
• W2893111821 hasBestOaLocation W28931118211 @default.
• W2893111821 hasConcept C126322002 @default.
• W2893111821 hasConcept C2776250341 @default.
• W2893111821 hasConcept C2777819096 @default.
• W2893111821 hasConcept C2778492647 @default.
• W2893111821 hasConcept C2778949068 @default.
• W2893111821 hasConcept C2779066535 @default.
• W2893111821 hasConcept C519063684 @default.
• W2893111821 hasConcept C71924100 @default.
• W2893111821 hasConcept C95190672 @default.
• W2893111821 hasConceptScore W2893111821C126322002 @default.
• W2893111821 hasConceptScore W2893111821C2776250341 @default.
• W2893111821 hasConceptScore W2893111821C2777819096 @default.
• W2893111821 hasConceptScore W2893111821C2778492647 @default.
• W2893111821 hasConceptScore W2893111821C2778949068 @default.
• W2893111821 hasConceptScore W2893111821C2779066535 @default.
• W2893111821 hasConceptScore W2893111821C519063684 @default.
• W2893111821 hasConceptScore W2893111821C71924100 @default.
• W2893111821 hasConceptScore W2893111821C95190672 @default.
• W2893111821 hasIssue "9" @default.
• W2893111821 hasLocation W28931118211 @default.
• W2893111821 hasLocation W28931118212 @default.
• W2893111821 hasLocation W28931118213 @default.
• W2893111821 hasLocation W28931118214 @default.
• W2893111821 hasLocation W28931118215 @default.
• W2893111821 hasOpenAccess W2893111821 @default.
• W2893111821 hasPrimaryLocation W28931118211 @default.
• W2893111821 hasRelatedWork W2006805568 @default.
• W2893111821 hasRelatedWork W2012535475 @default.
• W2893111821 hasRelatedWork W2053255232 @default.
• W2893111821 hasRelatedWork W2069341271 @default.
• W2893111821 hasRelatedWork W2075967653 @default.
• W2893111821 hasRelatedWork W213494063 @default.
• W2893111821 hasRelatedWork W2312861704 @default.
• W2893111821 hasRelatedWork W2355985602 @default.

• next